Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study
Aykut Cilli, Ismail Hanta, Fatih Uzer, Funda Coskun, Can Sevinc, Pelin Pınar Deniz, Mehmet Parlak, Ersoy Altunok, Kemal Can Tertemiz, Ahmet Ursavas
Respiratory Medicine and Research, doi:10.1016/j.resmer.2022.100900
Background: There are few data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19) infection in patients with idiopathic pulmonary fibrosis (IPF). The objective of this study is to describe the characteristics and outcomes of IPF patients confirmed COVID-19 infection. Methods: In this retrospective, multi-center, cohort study, patients from 4 hospital medical records with known IPF and a COVID-19 diagnosis were identified. Demographic and clinical outcome data were abstracted through a review of electronic medical records. Results: Records for 46 patients with IPF and COVID-19 were abstracted. The mean age was 65 § 10 years. The most common symptom was dyspnea, followed by fever and cough. Ground-glass opacities (n = 35, 83.3%) and consolidations (n = 11, 26.1%) were the main imaging features of the disease in thorax computed tomography (CT). Twenty-four patients (52.1%) required hospitalization. Among the hospitalized patients, 16 (66.6%) were admitted to the intensive care unit (ICU), and 10 (41.6%) underwent invasive mechanical ventilation. Thirteen patients (28.2%) died of COVID-19 complications. Mortality rate was significantly associated with lower DLCO/VA, long term oxygen therapy and consolidation finding on CT of thorax (p<0.05). On multivariable analysis, neither factor was associated with hospitalization or mortality. Conclusions: IPF patients represent a vulnerable population for COVID-19, according to the high rate of hospitalization, ICU requirement, and mortality rate. Measures to minimize the risk of COVID-19 infection remain key to protect IPF patients.
Conflict of Interest None.
References
Aloufi, Traboulsi, Ding, Fonseca, Nair et al., Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19, Am J Physiol Lung Cell Mol Physiol,
doi:10.1152/ajplung.00455.2020Drake, Docherty, Harrison, Quint, Adamali et al., Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study, Am J Respir Crit Care Med,
doi:10.1164/rccm.202007-2794OCEsposito, Menon, Ghosh, Putman, Fredenburgh et al., Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study, Am J Respir Crit Care Med,
doi:10.1164/rccm.202006-2441LEGallay, Uzunhan, Borie, Lazor, Rigaud et al., Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease, Am J Respir Crit Care Med,
doi:10.1164/rccm.202007-2638LEHuang, Zhang, Chen, Zhang, Wei et al., Clinical characteristics of COVID-19 in patients with pre-existing ILD: a retrospective study in a single center in Wuhan, China, J Med Virol,
doi:10.1002/jmv.26174Lee, Choi, Yang, Lee, Park et al., Interstitial lung disease increases susceptibility to and severity of COVID-19, Eur Respir J,
doi:10.1183/13993003.04125-2020Li, Liu, Hsu, Lin, Hsu et al., Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19, Part Fibre Toxicol,
doi:10.1186/s12989-021-00404-3Li, Wu, Wu, Guo, Chen et al., The clinical and chest CT features associated with severe and critical COVID-19 pneumonia, Invest Radiol,
doi:10.1097/RLI.0000000000000672Naqvi, Lakhani, Sohail, Maurer, Sofka et al., Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis, BMJ Open Respir Res,
doi:10.1136/bmjresp-2021-000969Pascarella, Strumia, Piliego, Bruno, Buono et al., COVID-19 diagnosis and management: a comprehensive review, J Intern Med,
doi:10.1111/joim.13091Raghu, Collard, Egan, Martinez, Behr et al., An Official ATS/ ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, Am J Respir Crit Care Med,
doi:10.1164/rccm.2009-040GLRajasurya, Gunasekaran, Damarla, Kolluru, A Fatal case of coronavirus disease 2019 (COVID-19) in a patient with idiopathic pulmonary fibrosis, Cureus n,
doi:10.7759/cureus.8432Tuite, Fisman, Odutayo, Bobos, Allen et al., COVID-19 hospitalizations, ICU admissions and deaths associated with the new variants of concern, Ontario COVID-19 Science Advisory Table,
doi:10.47326/ocsat.2021.02.18.1.0Wong, Fidler, Marcoux, Johannson, Assayag et al., Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic, Chest,
doi:10.1016/j.chest.2020.04.019Ye, Zhang, Wang, Huang, Song, Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review, Eur Radiol,
doi:10.1007/s00330-020-06801-0Yuan, Yin, Tao, Tan, Hu, Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China, PLoS ONE,
doi:10.1371/journal.pone.0230548{ 'indexed': {'date-parts': [[2022, 4, 2]], 'date-time': '2022-04-02T15:18:05Z', 'timestamp': 1648912685541},
'reference-count': 19,
'publisher': 'Elsevier BV',
'license': [ { 'start': { 'date-parts': [[2022, 5, 1]],
'date-time': '2022-05-01T00:00:00Z',
'timestamp': 1651363200000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}],
'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True},
'short-container-title': ['Respiratory Medicine and Research'],
'published-print': {'date-parts': [[2022, 5]]},
'DOI': '10.1016/j.resmer.2022.100900',
'type': 'journal-article',
'created': {'date-parts': [[2022, 3, 3]], 'date-time': '2022-03-03T01:30:28Z', 'timestamp': 1646271028000},
'page': '100900',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': ['Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study'],
'prefix': '10.1016',
'volume': '81',
'author': [ {'given': 'Aykut', 'family': 'Cilli', 'sequence': 'first', 'affiliation': []},
{'given': 'Ismail', 'family': 'Hanta', 'sequence': 'additional', 'affiliation': []},
{'given': 'Fatih', 'family': 'Uzer', 'sequence': 'additional', 'affiliation': []},
{'given': 'Funda', 'family': 'Coskun', 'sequence': 'additional', 'affiliation': []},
{'given': 'Can', 'family': 'Sevinc', 'sequence': 'additional', 'affiliation': []},
{'given': 'Pelin Pınar', 'family': 'Deniz', 'sequence': 'additional', 'affiliation': []},
{'given': 'Mehmet', 'family': 'Parlak', 'sequence': 'additional', 'affiliation': []},
{'given': 'Ersoy', 'family': 'Altunok', 'sequence': 'additional', 'affiliation': []},
{'given': 'Kemal Can', 'family': 'Tertemiz', 'sequence': 'additional', 'affiliation': []},
{'given': 'Ahmet', 'family': 'Ursavas', 'sequence': 'additional', 'affiliation': []}],
'member': '78',
'reference': [ { 'key': '10.1016/j.resmer.2022.100900_bib0001',
'unstructured': 'WHO Coronavirus (COVID-19) Dashboard n.d. https://covid19.who.int '
'(accessed October 27, 2021).'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0002',
'doi-asserted-by': 'crossref',
'first-page': '1069',
'DOI': '10.1016/j.chest.2020.04.019',
'article-title': 'Practical considerations for the diagnosis and treatment of fibrotic '
'interstitial lung disease during the coronavirus disease 2019 pandemic',
'volume': '158',
'author': 'Wong',
'year': '2020',
'journal-title': 'Chest'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0003',
'doi-asserted-by': 'crossref',
'first-page': '807',
'DOI': '10.1016/S2213-2600(20)30225-3',
'article-title': 'Pulmonary fibrosis and COVID-19: the potential role for antifibrotic '
'therapy',
'volume': '8',
'author': 'George',
'year': '2020',
'journal-title': 'Lancet Respirat Med'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0004',
'doi-asserted-by': 'crossref',
'first-page': '1656',
'DOI': '10.1164/rccm.202007-2794OC',
'article-title': 'Outcome of hospitalization for COVID-19 in patients with interstitial '
'lung disease. An international multicenter study',
'volume': '202',
'author': 'Drake',
'year': '2020',
'journal-title': 'Am J Respir Crit Care Med'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0005',
'doi-asserted-by': 'crossref',
'first-page': '1710',
'DOI': '10.1164/rccm.202006-2441LE',
'article-title': 'Increased odds of death for patients with interstitial lung disease and '
'COVID-19: a case-control study',
'volume': '202',
'author': 'Esposito',
'year': '2020',
'journal-title': 'Am J Respir Crit Care Med'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0006',
'doi-asserted-by': 'crossref',
'article-title': 'Interstitial lung disease increases susceptibility to and severity of '
'COVID-19',
'author': 'Lee',
'year': '2021',
'journal-title': 'Eur Respir J',
'DOI': '10.1183/13993003.04125-2020'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0007',
'doi-asserted-by': 'crossref',
'first-page': '245',
'DOI': '10.1164/rccm.202007-2638LE',
'article-title': 'Risk factors for mortality after COVID-19 in patients with preexisting '
'interstitial lung disease',
'volume': '203',
'author': 'Gallay',
'year': '2021',
'journal-title': 'Am J Respir Crit Care Med'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0008',
'doi-asserted-by': 'crossref',
'first-page': '788',
'DOI': '10.1164/rccm.2009-040GL',
'article-title': 'An Official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: '
'evidence-based guidelines for diagnosis and management',
'volume': '183',
'author': 'Raghu',
'year': '2011',
'journal-title': 'Am J Respir Crit Care Med'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0009',
'series-title': 'Ontario COVID-19 Science Advisory Table',
'article-title': 'COVID-19 hospitalizations, ICU admissions and deaths associated with '
'the new variants of concern',
'author': 'Tuite',
'year': '2021'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0010',
'doi-asserted-by': 'crossref',
'first-page': '192',
'DOI': '10.1111/joim.13091',
'article-title': 'COVID-19 diagnosis and management: a comprehensive review',
'volume': '288',
'author': 'Pascarella',
'year': '2020',
'journal-title': 'J Intern Med'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0011',
'doi-asserted-by': 'crossref',
'article-title': 'Clinical characteristics of COVID-19 in patients with pre-existing ILD: '
'a retrospective study in a single center in Wuhan, China',
'author': 'Huang',
'year': '2020',
'journal-title': 'J Med Virol',
'DOI': '10.1002/jmv.26174'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0012',
'doi-asserted-by': 'crossref',
'DOI': '10.1136/bmjresp-2021-000969',
'article-title': 'Patients with idiopathic pulmonary fibrosis have poor clinical outcomes '
'with COVID-19 disease: a propensity matched multicentre research '
'network analysis',
'volume': '8',
'author': 'Naqvi',
'year': '2021',
'journal-title': 'BMJ Open Respir Res'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0013',
'doi-asserted-by': 'crossref',
'unstructured': 'Rajasurya V., Gunasekaran K., Damarla V., Kolluru A. A Fatal case of '
'coronavirus disease 2019 (COVID-19) in a patient with idiopathic '
'pulmonary fibrosis. Cureus n.d. ;12:e8432. '
'https://doi.org/10.7759/cureus.8432.',
'DOI': '10.7759/cureus.8432'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0014',
'doi-asserted-by': 'crossref',
'first-page': '11',
'DOI': '10.1186/s12989-021-00404-3',
'article-title': 'Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic '
'pulmonary fibrosis: a potential role in severe COVID-19',
'volume': '18',
'author': 'Li',
'year': '2021',
'journal-title': 'Part Fibre Toxicol'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0015',
'doi-asserted-by': 'crossref',
'first-page': 'L152',
'DOI': '10.1152/ajplung.00455.2020',
'article-title': 'Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: '
'the forgotten cell in COVID-19',
'volume': '320',
'author': 'Aloufi',
'year': '2021',
'journal-title': 'Am J Physiol Lung Cell Mol Physiol'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0016',
'doi-asserted-by': 'crossref',
'first-page': '1614',
'DOI': '10.1164/rccm.202010-3918ED',
'article-title': 'COVID-19 and interstitial lung disease: keep them separate',
'volume': '202',
'author': 'Podolanczuk',
'year': '2020',
'journal-title': 'Am J Respir Crit Care Med'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0017',
'doi-asserted-by': 'crossref',
'DOI': '10.1371/journal.pone.0230548',
'article-title': 'Association of radiologic findings with mortality of patients infected '
'with 2019 novel coronavirus in Wuhan, China',
'volume': '15',
'author': 'Yuan',
'year': '2020',
'journal-title': 'PLoS ONE'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0018',
'doi-asserted-by': 'crossref',
'first-page': '327',
'DOI': '10.1097/RLI.0000000000000672',
'article-title': 'The clinical and chest CT features associated with severe and critical '
'COVID-19 pneumonia',
'volume': '55',
'author': 'Li',
'year': '2020',
'journal-title': 'Invest Radiol'},
{ 'key': '10.1016/j.resmer.2022.100900_bib0019',
'doi-asserted-by': 'crossref',
'first-page': '4381',
'DOI': '10.1007/s00330-020-06801-0',
'article-title': 'Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a '
'pictorial review',
'volume': '30',
'author': 'Ye',
'year': '2020',
'journal-title': 'Eur Radiol'}],
'container-title': ['Respiratory Medicine and Research'],
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S2590041222000174?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S2590041222000174?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2022, 3, 23]],
'date-time': '2022-03-23T17:37:46Z',
'timestamp': 1648057066000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S2590041222000174'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 5]]},
'references-count': 19,
'alternative-id': ['S2590041222000174'],
'URL': 'http://dx.doi.org/10.1016/j.resmer.2022.100900',
'relation': {},
'ISSN': ['2590-0412'],
'issn-type': [{'value': '2590-0412', 'type': 'print'}],
'subject': ['Pulmonary and Respiratory Medicine'],
'published': {'date-parts': [[2022, 5]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'Characteristics and outcomes of COVID-19 patients with IPF: A multi-center '
'retrospective study',
'name': 'articletitle',
'label': 'Article Title'},
{ 'value': 'Respiratory Medicine and Research',
'name': 'journaltitle',
'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.resmer.2022.100900',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': '© 2022 SPLF and Elsevier Masson SAS. All rights reserved.',
'name': 'copyright',
'label': 'Copyright'}],
'article-number': '100900'}
